Protocol to request
In vivo isogenic Leukemia and irinotecan treatment (diagrammed in Figure 4A)
Research article
Kinase-dead ATM protein is highly oncogenic and can be preferentially targeted by Topo-isomerase I inhibitors
Kenta Yamamoto et al.
DOI: 10.7554/eLife.14709